Market Overview

MediPharm Labs Revenue Rises 115% Quarter-Over-Quarter

MediPharm Labs Revenue Rises 115% Quarter-Over-Quarter

MediPharm Labs Corp. (OTC: MEDIF) announced first-quarter financial results Friday.

The global extraction, distillation, purification and cannabinoid isolation company generated revenue of $22 million, a 115-percent increase from the fourth quarter of 2018.

MediPharm posted a $6.9-million gross profit with a 31-percent gross margin. The company's adjusted EBITDA of $4.3 million marked a 102-percent increase over the fourth quarter of 2018 and a 20-percent margin. The company reported a net loss of $573,000 for the quarter. 

Other highlights that were mentioned include the acquisition of more than 5 million grams of dried cannabis during the last two weeks of the quarter.

The quarterly print sets the pace for "continued robust growth," MediPharm CEO Patrick McCutcheon said in a statement. 

“Our revenue and adjusted EBITDA performance ... illustrates the value of our specialized focus and ability to execute as the Canadian market's leading extraction experts and providers of high-quality cannabinoid-based derivative formulations at scale."

MediPharm's next steps include advancing efforts around distillate; white label solutions; topicals; and vaporized items, the CEO said.

“Our white label offering will be an enduring advantage and attractive solution for LP’s, direct-to-consumer brands and CPG companies, which we expect will also accelerate our growth in the months and years ahead.”

Related Links:

MediPharm Labs Hits 331-Pound Cannabis Extraction Milestone

MediPharm Labs, Pure Global Cannabis, Weekend Unlimited, Plus Products, Trulieve Make Elevator Pitches

Posted-In: marijuana pot weedCannabis Earnings News Guidance Markets Best of Benzinga


Related Articles (MEDIF)

View Comments and Join the Discussion!

Cannabis Movers

Sign up for our secret cannabis newsletter!
Never miss out on the breaking news in the Cannabis Industry!

2 Analysts Turn Incrementally Bullish On IAC InterActive

Mid-Afternoon Market Update: Qurate Retail Falls After Q1 Results; Genetic Technologies Shares Surge